Deaths due to absence of an affordable antitoxin for plant poisoning

Show simple item record

dc.contributor.author Eddleston, M.
dc.contributor.author Senarathna, L.
dc.contributor.author Mohamed, F.
dc.contributor.author Buckley, N.
dc.contributor.author Juszczak, E.
dc.contributor.author Sheriff, M.H.R.
dc.contributor.author Ariaratnam, C.A.
dc.contributor.author Rajapakse, S.
dc.contributor.author Warrell, D.
dc.contributor.author Rajakanthan, K.
dc.date.accessioned 2011-11-21T11:06:44Z
dc.date.available 2011-11-21T11:06:44Z
dc.date.issued 2003
dc.identifier.citation Lancet. 2003 Sep 27;362(9389):1041-4 en_US
dc.identifier.uri http://archive.cmb.ac.lk:8080/xmlui/handle/70130/463
dc.description.abstract There is a severe shortage of affordable antivenoms and antitoxins in the developing world. An anti-digoxin antitoxin for oleander poisoning was introduced in Sri Lanka in July, 2001, but because of its cost, stocks ran out in July, 2002. We looked at the effect of its introduction and withdrawal on case fatality, and determined its cost-effectiveness. The antitoxin strikingly reduced the case fatality; its absence resulted in a three-fold rise in deaths. At the present price of US2650 dollars per course, every life saved cost 10209 dollars and every life year cost 248 dollars. Reduction of the antitoxin's price to 400 dollars would reduce costs to 1137 dollars per life gained; a further reduction to 103 dollars would save money for every life gained. Treatments for poisoning and envenoming should be included in the present campaign to increase availability of affordable treatments in the developing world. en_US
dc.language.iso en en_US
dc.title Deaths due to absence of an affordable antitoxin for plant poisoning en_US
dc.type Journal abstract en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account